Literature DB >> 15210842

Remodeling of HDL remnants generated by scavenger receptor class B type I.

Nancy R Webb1, Maria C de Beer, Bela F Asztalos, Nathan Whitaker, Deneys R van der Westhuyzen, Frederick C de Beer.   

Abstract

Scavenger receptor class B type I (SR-BI) mediates the selective transfer of cholesteryl ester from HDL to cells. We previously established that SR-BI overexpressed in livers of apolipoprotein A-I-deficient mice processes exogenous human HDL2 to incrementally smaller HDL particles. When mixed with normal mouse plasma either in vivo or ex vivo, SR-BI-generated HDL "remnants" rapidly remodel to form HDL-sized lipoproteins. In this study, we analyzed HDLs throughout the process of HDL remnant formation and investigated the mechanism of conversion to larger particles. Upon interacting with SR-BI, alpha-migrating HDL2 is initially converted to a prealpha-migrating particle that is ultimately processed to a smaller alpha-migrating HDL remnant. SR-BI does not appear to generate prebeta-1 HDL particles. When incubated with isolated lipoprotein fractions, HDL remnants are converted to lipoprotein particles corresponding in size to the particle incubated with the HDL remnant. HDL remnant conversion is not altered in phospholipid transfer protein (PLTP)-deficient mouse plasma or by the addition of purified PLTP. Although LCAT-deficient plasma promoted only partial conversion, this deficiency was attributable to the nature of HDL particles in LCAT-/- mice rather than to a requirement for LCAT in the remodeling process. We conclude that HDL remnants, generated by SR-BI, are converted to larger particles by rapidly reassociating with existing HDL particles in an enzyme-independent manner. Copyright 2004 American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15210842     DOI: 10.1194/jlr.M400026-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  8 in total

1.  An integrated approach for the mechanisms responsible for atherosclerotic plaque regression.

Authors:  Andrew A Francis; Grant N Pierce
Journal:  Exp Clin Cardiol       Date:  2011

2.  Scavenger receptor B1 (SR-B1) profoundly excludes high density lipoprotein (HDL) apolipoprotein AII as it nibbles HDL-cholesteryl ester.

Authors:  Baiba K Gillard; G Randall Bassett; Antonio M Gotto; Corina Rosales; Henry J Pownall
Journal:  J Biol Chem       Date:  2017-04-03       Impact factor: 5.157

3.  Apolipoprotein E mediates enhanced plasma high-density lipoprotein cholesterol clearance by low-dose streptococcal serum opacity factor via hepatic low-density lipoprotein receptors in vivo.

Authors:  Corina Rosales; Daming Tang; Baiba K Gillard; Harry S Courtney; Henry J Pownall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-05-19       Impact factor: 8.311

Review 4.  Macrophage cholesterol homeostasis and metabolic diseases: critical role of cholesteryl ester mobilization.

Authors:  Shobha Ghosh
Journal:  Expert Rev Cardiovasc Ther       Date:  2011-03

5.  High-density lipoprotein subpopulation profiles in lipoprotein lipase and hepatic lipase deficiency.

Authors:  Mariko Tani; Katalin V Horvath; Benoit Lamarche; Patrick Couture; John R Burnett; Ernst J Schaefer; Bela F Asztalos
Journal:  Atherosclerosis       Date:  2016-08-20       Impact factor: 5.162

6.  SR-BI selective lipid uptake: subsequent metabolism of acute phase HDL.

Authors:  Maria C de Beer; Nancy R Webb; Nathan L Whitaker; Joanne M Wroblewski; Anisa Jahangiri; Deneys R van der Westhuyzen; Frederick C de Beer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-03-19       Impact factor: 8.311

7.  Functional characterization of newly-discovered mutations in human SR-BI.

Authors:  Alexandra C Chadwick; Daisy Sahoo
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

Review 8.  Pathways and Mechanisms of Cellular Cholesterol Efflux-Insight From Imaging.

Authors:  Alice Dupont Juhl; Daniel Wüstner
Journal:  Front Cell Dev Biol       Date:  2022-03-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.